Date
2020-09-17Journal
BMJPublisher
BMJ Publishing GroupType
Article
Metadata
Show full item recordDescription
It seemed a truth universally acknowledged that the human population had no pre-existing immunity to SARS-CoV-2, but is that actually the case? Peter Doshi explores the emerging research on immunological responses.Keyword
Coronavirus Disease 2019 (COVID-19)COVID-19 (Disease)
COVID-19
Immunity, Herd
SARS-CoV-2--immunology
T-Lymphocytes--immunology
Identifier to cite or link to this item
http://hdl.handle.net/10713/13734ae974a485f413a2113503eed53cd6c53
10.1136/bmj.m3563
Scopus Count
Related articles
- Immune Correlates of COVID-19 Control.
- Authors: Poonia B, Kottilil S
- Issue date: 2020
- Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19.
- Authors: Varadhachary A, Chatterjee D, Garza J, Garr RP, Foley C, Letkeman AF, Dean J, Haug D, Breeze J, Traylor R, Malek A, Nath R, Linbeck L
- Issue date: 2020 Aug 11
- [Position paper of the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft, ÖAG) : Effects of the COVID-19 pandemic in Austria on people with dementia and their care environment-problem areas, recommendations, and strategies].
- Authors: Defrancesco M, Bancher C, Dal-Bianco P, Hinterhuber H, Schmidt R, Struhal W, Ransmayr G, Stögmann E, Marksteiner J
- Issue date: 2020 Oct 29
- Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?.
- Authors: Fausther-Bovendo H, Kobinger GP
- Issue date: 2014
- Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.
- Authors: Croyle MA, Patel A, Tran KN, Gray M, Zhang Y, Strong JE, Feldmann H, Kobinger GP
- Issue date: 2008